MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/s12885-025-14758-w

Медицинская библиотека · BMC cancer · 2025

Molecular mechanisms of astragaloside-IV in hepatocellular carcinoma therapy: a systematic review.

Gao Xin, Hao Wen, Wang Yike, Wu Xiaqiu, Zhu Feiye, Zhang Yongsheng

СтатьяСистематический обзорПеревод пока не подготовлен

Аннотация

BACKGROUND

Astragaloside IV (AS-IV), a key monomeric compound extracted from the traditional Chinese medicine Astragalus membranaceus, has demonstrated significant therapeutic potential in cancer treatment. Hepatocellular carcinoma (HCC), as a malignant tumor posing severe threats to global health, is characterized by high incidence and mortality rates, imposing substantial burdens on patients, families, and society. Numerous studies have demonstrated that AS-IV exhibits significant inhibitory effects on HCC. However, the precise underlying mechanisms remain unclear. Therefore, this systematic review provides a comprehensive summary of current research findings.

METHODS

This systematic review comprehensively evaluates the molecular mechanisms of AS-IV in HCC through extensive literature retrieval from five authoritative databases, encompassing studies published from their inception to March 2025.

RESULTS

A total of 172 potentially relevant articles were retrieved through database search. After screening, a total of 16 articles finally met the qualification criteria.

CONCLUSION

Current evidence indicates that AS-IV exerts crucial therapeutic effects in HCC through multiple pathways: inhibiting tumor cell proliferation, migration, and invasion; inducing apoptosis; modulating immune responses; reducing drug resistance while enhancing chemosensitivity; and suppressing angiogenesis. However, large-scale, well-designed multicenter randomized controlled trials are warranted to establish more robust clinical evidence, thereby solidifying the foundation for AS-IV's broader application in HCC therapeutics.

Для цитирования: Gao Xin, Hao Wen, Wang Yike, Wu Xiaqiu, Zhu Feiye, Zhang Yongsheng. Molecular mechanisms of astragaloside-IV in hepatocellular carcinoma therapy: a systematic review.. BMC cancer. 2025. DOI: 10.1186/s12885-025-14758-w.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.